CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-27. Amounts in USD.

Revenue TTM

0 1.5B 3B 4.5B Q3 '16: 1.6B Q4 '16: 1.7B Q2 '17: 1.8B Q3 '17: 1.8B Q3 '17: 1.8B Q4 '17: 1.9B Q1 '18: 1.9B Q2 '18: 2B Q3 '18: 2.1B Q4 '18: 2.3B Q1 '19: 2.4B Q2 '19: 2.4B Q3 '19: 2.5B Q4 '19: 2.6B Q1 '20: 2.7B Q2 '20: 2.7B Q3 '20: 2.8B Q4 '20: 2.9B Q1 '21: 3B Q2 '21: 3.3B Q3 '21: 3.4B Q4 '21: 3.5B Q1 '22: 3.6B Q2 '22: 3.7B Q3 '22: 3.8B Q4 '22: 4B Q2 '23: 4.1B Q3 '23: 4.2B Q3 '23: 4.2B Q4 '23: 4.1B Q1 '24: 4.1B Q2 '24: 4.1B Q3 '24: 4.1B Q4 '24: 4B Q1 '25: 4B Q2 '25: 4B Q3 '25: 4B Q4 '25: 4B Q1 '26: 4B Q2 '26: 4B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 400M 800M 1.2B Q4 '13: 394.9M Q1 '14: 399.5M Q2 '14: 422.6M Q3 '14: 440.9M Q4 '14: 472.7M Q1 '15: 483.5M Q2 '15: 490.7M Q3 '15: 510.5M Q4 '15: 531.1M Q1 '16: 552.2M Q2 '16: 589.2M Q3 '16: 607.4M Q4 '16: 646.7M Q2 '17: 677.2M Q3 '17: 692.8M Q3 '17: 713.4M Q4 '17: 700.9M Q1 '18: 711M Q2 '18: 741.7M Q3 '18: 781M Q4 '18: 840.1M Q1 '19: 870.4M Q2 '19: 892.5M Q3 '19: 922.4M Q4 '19: 958.3M Q1 '20: 998.6M Q2 '20: 992.7M Q3 '20: 1B Q4 '20: 1.1B Q4 '13 Q4 '14 Q4 '15 Q4 '16 Q4 '17 Q4 '18 Q4 '19 Q4 '20

Operating Income TTM

0 250M 500M 750M Q4 '14: 177.7M Q1 '15: 181M Q2 '15: 185.7M Q3 '15: 194.9M Q4 '15: 206.4M Q1 '16: 214.9M Q2 '16: 217.2M Q3 '16: 220.6M Q4 '16: 237.4M Q2 '17: 255.7M Q3 '17: 279.3M Q3 '17: 294.5M Q4 '17: 288.3M Q1 '18: 286.4M Q2 '18: 281.4M Q3 '18: 291.7M Q4 '18: 331.4M Q1 '19: 333.3M Q2 '19: 336.4M Q3 '19: 344.8M Q4 '19: 351.2M Q1 '20: 375.6M Q2 '20: 372.6M Q3 '20: 412.6M Q4 '20: 432.7M Q1 '21: 462.2M Q2 '21: 522.9M Q3 '21: 546M Q4 '21: 589.9M Q1 '22: 614.9M Q2 '22: 664.8M Q3 '22: 660M Q4 '22: 651M Q2 '23: 670.1M Q3 '23: 647.6M Q3 '23: 648.1M Q4 '23: 617.3M Q1 '24: 575.3M Q2 '24: 562.1M Q3 '24: 528M Q4 '15 Q2 '17 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q3 '23 Q3 '24

Net Income TTM

-400M -200M 0 200M 400M 600M Q3 '15: 145.1M Q4 '15: 149.3M Q1 '16: 154.9M Q2 '16: 141.6M Q3 '16: 142M Q4 '16: 154.8M Q2 '17: 164.4M Q3 '17: 183.1M Q3 '17: 197.9M Q4 '17: 123.4M Q1 '18: 129.2M Q2 '18: 129M Q3 '18: 136.9M Q4 '18: 226.4M Q1 '19: 228.9M Q2 '19: 218.9M Q3 '19: 231.3M Q4 '19: 252M Q1 '20: 247.7M Q2 '20: 271.4M Q3 '20: 301.5M Q4 '20: 364.3M Q1 '21: 375.1M Q2 '21: 396.1M Q3 '21: 396.6M Q4 '21: 391M Q1 '22: 422.5M Q2 '22: 443.3M Q3 '22: 436.4M Q4 '22: 486.2M Q2 '23: 496.3M Q3 '23: 484M Q3 '23: 474.9M Q4 '23: 474.6M Q1 '24: 444.5M Q2 '24: 441.5M Q3 '24: 423.8M Q4 '25: -144.3M Q1 '26: -184.7M Q2 '26: -238.5M Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 300M 600M 900M Q3 '16: 319.2M Q4 '16: 316.9M Q2 '17: 305.1M Q3 '17: 325.3M Q3 '17: 312.5M Q4 '17: 318.1M Q1 '18: 344.1M Q2 '18: 367.6M Q3 '18: 425.4M Q4 '18: 441.1M Q1 '19: 395.9M Q2 '19: 401.6M Q3 '19: 440.2M Q4 '19: 480.9M Q1 '20: 534.7M Q2 '20: 567.4M Q3 '20: 588.9M Q4 '20: 546.6M Q1 '21: 648.2M Q2 '21: 672.5M Q3 '21: 669.9M Q4 '21: 760.8M Q1 '22: 693.2M Q2 '22: 656.1M Q3 '22: 614.1M Q4 '22: 619.6M Q2 '23: 626.4M Q3 '23: 625M Q3 '23: 697.7M Q4 '23: 683.9M Q1 '24: 704.4M Q2 '24: 749.8M Q3 '24: 796.2M Q4 '24: 734.6M Q1 '25: 776.4M Q2 '25: 787.5M Q3 '25: 749.5M Q4 '25: 737.6M Q1 '26: 607M Q2 '26: 582.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

0 200M 400M 600M Q3 '16: 261.3M Q4 '16: 261.6M Q2 '17: 242.1M Q3 '17: 258.1M Q3 '17: 232.9M Q4 '17: 235.6M Q1 '18: 249.9M Q2 '18: 268.2M Q3 '18: 325.5M Q4 '18: 301.1M Q1 '19: 266.9M Q2 '19: 269M Q3 '19: 294.9M Q4 '19: 340.4M Q1 '20: 385.2M Q2 '20: 415.9M Q3 '20: 446.3M Q4 '20: 380M Q1 '21: 479.3M Q2 '21: 484M Q3 '21: 452.1M Q4 '21: 532M Q1 '22: 412M Q2 '22: 338.5M Q3 '22: 279.7M Q4 '22: 294.9M Q2 '23: 275.2M Q3 '23: 289.4M Q3 '23: 368.5M Q4 '23: 365.4M Q1 '24: 413.6M Q2 '24: 486.9M Q3 '24: 560.5M Q4 '24: 501.6M Q1 '25: 563.2M Q2 '25: 578.5M Q3 '25: 543.7M Q4 '25: 518.5M Q1 '26: 391.3M Q2 '26: 370.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '13: 48.8M Q3 '13: 48.4M Q1 '14: 48.2M Q2 '14: 47.7M Q3 '14: 46.9M Q1 '15: 47.9M Q2 '15: 47.5M Q3 '15: 47.2M Q1 '16: 47.6M Q2 '16: 47.9M Q3 '16: 48M Q2 '17: 48.4M Q3 '17: 48.3M Q3 '17: 48.4M Q1 '18: 48.8M Q2 '18: 49M Q3 '18: 49.3M Q1 '19: 49.5M Q2 '19: 49.7M Q3 '19: 49.7M Q1 '20: 50M Q2 '20: 50.2M Q3 '20: 50.7M Q1 '21: 51.1M Q2 '21: 51.3M Q3 '21: 51.6M Q1 '22: 51.3M Q2 '22: 51.3M Q3 '22: 51.3M Q2 '23: 51.4M Q3 '23: 51.5M Q3 '23: 51.6M Q1 '24: 51.8M Q2 '24: 51.8M Q3 '24: 51.6M Q1 '25: 50.9M Q2 '25: 49.3M Q3 '25: 49.4M Q1 '26: 49M Q2 '26: 48M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q2 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.00 -3.50 0.00 3.50 7.00 10.50 Q3 '15: 3.04 Q4 '15: 3.14 Q1 '16: 3.26 Q2 '16: 2.97 Q3 '16: 2.97 Q4 '16: 3.23 Q2 '17: 3.42 Q3 '17: 3.81 Q3 '17: 4.10 Q4 '17: 2.54 Q1 '18: 2.65 Q2 '18: 2.63 Q3 '18: 2.77 Q4 '18: 4.61 Q1 '19: 4.64 Q2 '19: 4.42 Q3 '19: 4.66 Q4 '19: 5.06 Q1 '20: 4.97 Q2 '20: 5.43 Q3 '20: 6.00 Q4 '20: 7.20 Q1 '21: 7.38 Q2 '21: 7.76 Q3 '21: 7.74 Q4 '21: 7.60 Q1 '22: 8.21 Q2 '22: 8.62 Q3 '22: 8.49 Q4 '22: 9.47 Q2 '23: 9.67 Q3 '23: 9.43 Q3 '23: 9.24 Q4 '23: 9.23 Q1 '24: 8.52 Q2 '24: 8.37 Q3 '24: 8.01 Q4 '25: -2.90 Q1 '26: -3.70 Q2 '26: -4.79 Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.